Oculis
Quick facts
Phase 3 pipeline
- OCS-01 · Ophthalmology
OCS-01 is an anti-vascular endothelial growth factor (VEGF) inhibitor.
Phase 2 pipeline
- Dexamethasone nanoparticles eye drops · Ophthalmology
Glucocorticoid receptor agonist
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: